Light Street Capital Management, LLC Finch Therapeutics Group, Inc. Transaction History

Light Street Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.91 - $5.11 $1.28 Million - $3.42 Million	-668,757 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.02 - $10.47 $717,729 - $1.5 Million	-142,974 Reduced 17.61%	668,757 $3.36 Million
Q4 2021 Feb 14, 2022	BUY	$8.95 - $16.88 $128,879 - $243,072	14,400 Added 1.81%	811,731 $8.09 Million
Q3 2021 Nov 15, 2021	BUY	$12.2 - $16.75 $7.67 Million - $10.5 Million	629,001 Added 373.67%	797,331 $10.4 Million
Q2 2021 Aug 16, 2021	BUY	$12.03 - $17.51 $2.03 Million - $2.95 Million	168,330 New	168,330 $2.37 Million

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $546M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Light Street Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Light Street Capital Management, LLC with notifications on news.